Tech Company Financing Transactions
Ancora Heart Funding Round
On 5/31/2018, Ancora Heart announced $17.8 million in funding from Savitr Capital and private investors.
Transaction Overview
Company Name
Announced On
5/31/2018
Transaction Type
Venture Equity
Amount
$17,800,000
Round
Undisclosed
Investors
Savitr Capital (Lead Investor)
Proceeds Purpose
The financing will be used to support clinical trials evaluating safety and efficacy of the AccuCinch, as well as ongoing product development efforts.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
4001 Burton Dr.
Santa Clara, CA 95054
USA
Santa Clara, CA 95054
USA
Phone
Website
Email Address
Overview
We are a medical device company based in Santa Clara, CA, dedicated to helping people with heart failure and functional mitral regurgitation (FMR) feel better and live longer. We developed AccuCinch, the first percutaneous ventricular repair (PVR) system designed to treat FMR, which is caused by heart failure.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jeffrey Closs
Chief Technical Officer
Russel Sampson
Vice President
Christine Tjossem
VP - Marketing
Bart Beasley
VP - Regulatory Affairs
Michael Fritz
VP - Regulatory Affairs
Michael Zapien
Browse more venture capital transactions:
Prev: 5/31/2018: Ava Sensor venture capital transaction
Next: 5/31/2018: SQream venture capital transaction
Share this article
About Database of VC Transactions
Our team works diligently to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs